Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/693
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUprety, Prof. Dr. Dhruba
dc.date.accessioned2012-12-28T05:24:40Z
dc.date.accessioned2022-11-08T10:18:28Z-
dc.date.available2012-12-28T05:24:40Z
dc.date.available2022-11-08T10:18:28Z-
dc.date.issued2012-12-27
dc.identifier.urihttp://103.69.126.140:8080/handle/20.500.14356/693-
dc.descriptionIntroduction Preterm birth is the major cause of neonatal mortality and morbidity. In addition, prematurity is strongly associated with long-term developmental disabilities, accounting for 1 in 5 children with mental retardation, 1 in 3 children with vision impairment, and almost half of children with cerebral palsy. So, prevention of preterm birth is a public health priority. Methods A randomized controlled trial was undertaken in BP Koirala Institute of Health Sciences, where 60 patients were randomized into group 1 (n=29, weekly intramuscular Progesterone) and group 2 ( n=31,no treatment) after the arrest of preterm labor with tocolysis. Their latency period till delivery and recurrence of preterm labor and neonatal outcomes were compared. Results There was significant reduction in recurrence of preterm labor and increase in latency period in progesterone group. However neonatal outcomes were similar. Conclusion Progesterone is useful in reducing the recurrence of preterm labor in a patient who had preterm labor.en_US
dc.language.isoen_USen_US
dc.subjectProgesteroneen_US
dc.subjectTocolysisen_US
dc.subjectPreterm laboren_US
dc.titleProgesterone for prevention of recurrent preterm labor after threatened preterm labor -A randomized controlled trialen_US
dc.typeTechnical Reporten_US
Appears in Collections:Post Graduate Grant (PG) Reports

Files in This Item:
File Description SizeFormat 
617.pdfFull Report153.15 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.